NDC 50090-3131-00 - Liothyronine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-3131
- Requested NDC
- 50090-3131-00
- Package NDCs from labels
- 50090-3131-1, 50090-3131-0, 50090-3131-00
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-01-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Liothyronine Sodium - A-S Medication Solutions | A-S Medication Solutions | 2024-01-26 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-3131-0 | Liothyronine Sodium | 100 in 1 BOTTLE | TABLET | 100 | 11 | |
| 50090-3131-1 | Liothyronine Sodium | 90 in 1 BOTTLE | TABLET | 90 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-3131 | LIOTHYRONINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 11 | Current NDC, Legacy NDC, 2 package rows | 20240131_db65bcd8-e9c9-4095-9975-03be1f443823.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-3131-0 | EA - Each | 50090-3131 | 3d498542-a062-421a-b60c-9774e6a8f039 | 1 | 2019-05-02 |
| 50090-3131-1 | EA - Each | 50090-3131 | c4aa75a3-337b-4005-8165-b1a670c350b1 | 1 | 2019-05-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Liothyronine Sodium | LIOTHYRONINE SODIUM | Mylan Pharmaceuticals Inc. | 115a84c2-0126-4dd7-816e-1873875f1e49 | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 903456 903697 903703 GCA9VV7D2N |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | Preferred Pharmaceuticals Inc. | 57744c7c-af44-4bc4-a5a8-79f05710f469 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903456 GCA9VV7D2N |
| Cytomel | LIOTHYRONINE SODIUM | Pfizer Laboratories Div Pfizer Inc | 51452b31-ff68-4e0c-b982-c15502ebf1d3 | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | 903456 903697 903703 GCA9VV7D2N |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | ASCLEMED USA INC. | 26cf6872-f4d4-41dd-8957-a000f13efbb3 | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903456 903697 903703 GCA9VV7D2N |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Liomny | LIOTHYRONINE SODIUM | SIGMAPHARM LABORATORIES, LLC | 0dcec611-2b7a-4cf3-80c3-7389be2f0a94 | 2025-11-21 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903456 903697 903703 GCA9VV7D2N |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | PD-Rx Pharmaceuticals, Inc. | 76fa4eb6-fefa-4e97-9543-f81e465743e6 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903697 GCA9VV7D2N |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | 9083a01b-2fbe-4e04-9eec-bf4f65950ec7 | 2025-09-09 | Warnings | 4846Q921YM |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM ,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | c14c79ab-85bb-45f2-83d1-1d9c298ffdfd | 2025-09-08 | Warnings | 4846Q921YM |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| Schuessler Tissue Salts Comb D Skin Disorders | KALI MURIATICUM,KALI SULPHURICUM,CALCAREA SULPHURICA,SILICEA | Martin & Pleasance Pty Ltd | 617303f8-4463-4a1e-a502-44abc181d91f | 2025-08-13 | Warnings | 4846Q921YM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.